Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
25.00
+0.76 (3.14%)
Apr 28, 2025, 4:00 PM EDT - Market closed

KMTS Cash Flow Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Year
TTM FY 2024 FY 2023 FY 2021 FY 2020
Period Ending
Jan '25 Apr '24 Apr '23 Apr '21 Apr '20
Net Income
-84.05-94.12-84.24-34.1-29.47
Depreciation & Amortization
9.6311.564.860.420.48
Other Amortization
1.230.610.450.15-
Loss (Gain) From Sale of Assets
1.611.070.56-00
Stock-Based Compensation
2.351.491.211.86-
Other Operating Activities
0.412.776.231.790.7
Change in Accounts Receivable
-6.53-2---
Change in Inventory
-2.47-1.18-0.73--
Change in Accounts Payable
4.667.342.14-0.13-0.79
Change in Other Net Operating Assets
4.310.22-0.110.11-1.22
Operating Cash Flow
-68.86-72.24-69.64-29.9-30.29
Capital Expenditures
-19.75-12.51-15.46-0.34-0.23
Sale of Property, Plant & Equipment
---0-
Other Investing Activities
0.040.29---
Investing Cash Flow
-19.71-12.23-15.46-0.33-0.23
Long-Term Debt Issued
-45-20-
Long-Term Debt Repaid
--39.12-5.33--
Net Debt Issued (Repaid)
-5.88-5.3320-
Issuance of Common Stock
---30.3330.42
Other Financing Activities
11.9-3.15-0.67-1.52-0.18
Financing Cash Flow
127.877.7396.1148.8230.24
Net Cash Flow
39.23-6.741118.59-0.29
Free Cash Flow
-88.61-84.75-85.1-30.23-30.53
Free Cash Flow Margin
-168.33%-304.70%-1115.37%--
Free Cash Flow Per Share
-837.41-800.97-804.32-285.72-288.49
Cash Interest Paid
4.833.63---
Cash Income Tax Paid
--0.030.010.210.07
Levered Free Cash Flow
--40.92--18.53-
Unlevered Free Cash Flow
--37.63--17.95-
Change in Net Working Capital
--15--0.54-
Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q